Matthew Shair

Matthew Shair

Founder at NUVALENT, INC.

Net worth: 133 M $ as of 31/03/2024

55 year
Consumer Services
Health Technology

Profile

Matthew D.
Shair
is the founder of Infinity Pharmaceuticals, Inc. (founded in 1995) and Nuvalent, Inc. (founded in 2017).
He is also the founder of Chemiderm, Inc., Makoto Life Sciences, Inc...
Dr. Shair's current job(s) include being a Professor at Harvard University (since 1997) and an Associate at Harvard Stem Cell Institute.
Dr. Shair's education history includes an undergraduate degree from Rochester Christian University, a doctorate degree from The Trustees of Columbia University in The City of New York, and a graduate degree from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/04/2024 1,775,720 ( 3.03% ) 133 M $ 31/03/2024

Matthew Shair active positions

CompaniesPositionStart
NUVALENT, INC. Founder 01/01/2017
Corporate Officer/Principal 01/06/1997
Corporate Officer/Principal -
All active positions of Matthew Shair

Former positions of Matthew Shair

CompaniesPositionEnd
Makoto Life Sciences, Inc. Founder -
Chemiderm, Inc. Founder -
INFINITY PHARMACEUTICALS, INC. Founder -
See the detail of Matthew Shair's experience

Training of Matthew Shair

Rochester Christian University Undergraduate Degree
The Trustees of Columbia University in The City of New York Doctorate Degree
Yale University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Shair's experience

Connections

95

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INFINITY PHARMACEUTICALS, INC.

Health Technology

NUVALENT, INC.

Health Technology

Private companies3

Health Technology

Chemiderm, Inc.

Makoto Life Sciences, Inc.

See company connections